ReviewJournal of immunology research2016

Involvement of HMGB1 in Resistance to Tumor Vessel-Targeted, Monoclonal Antibody-Based Immunotherapy.

Vito Pistoia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.